We are looking for young people 2 to 17 years old to join a Crohn’s disease (CD) clinical trial to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or moderate to severe Crohn’s disease (including associated symptoms such as recurrent diarrhea, loss of appetite, abdominal pain, malnutrition and/or canker sores), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.
Your child may be eligible to take part in the IBD clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child is eligible.
